This year, an international collaboration project under the supervision of the Ministry of Health discovered a new drug, which has shown to have a particularly strong effect on tumors. The research team reported that the drug kills cancer cells by blocking specific enzymes within the cell while protecting healthy cells.
The drug was used for prevention and treatment in early phase clinical trials, reducing tumor size in 78% of patients and stopping disease progression in 65%. Patient-centered feedback was also satisfactory, with side effects ranging from mild gastrointestinal discomfort to general fatigue.
The discovery is opening up new possibilities in the science community: The drug could be made compatible not only with hard tissue cancers but also with blood and advanced immunotherapies. Researchers are working on the long-term use, economic feasibility and global reach of the drug in further stages.
